Allergo oncology: Targeted degranulation
Alleamit, Inc., Minnesota, USA.
Review
Open Access Research Journal of Science and Technology, 2023, 08(01), 011–013.
Article DOI: 10.53022/oarjst.2023.8.1.0026
Publication history:
Received on 07 April 2023; revised on 13 May 2023; accepted on 16 May 2023
Abstract:
Allergies are an inevitable part of life, no matter where we live. Without a doubt, the symptoms of allergies can cause severe physical and mental suffering. Although medical science has made great strides in suppressing allergy symptoms with medicines, immunotherapies, and virus-like particle technology (i.e., Allergy Vaccines), research indicates that allergies may be nature's cancer immunotherapy. Targeted degranulation explores breaking the immune-tolerance cancer barrier. This review will discuss how IgE-primed effector cells and allergenic vaccines may inhibit solid tumor progression.
Keywords:
Allergies; Cancer; Immunotherapy; Skin Cream; Allergenic Vaccine
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0